H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|17|10|926-929

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.17, Iss.10, 2016-08, pp. : 926-929

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunny outlook for personalized medicine: tamoxifen and beyond

By Teft Wendy A   Kim Richard B  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1533-1536

Future Medicine

Access to resources Recommend Favorite

Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 3, 2017-04 ,pp. : 221-230

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 1-5

Bentham Science Publishers

Access to resources Recommend Favorite

Nanotheranostics for personalized medicine

By Kim Tae Hyung   Lee Seulki   Chen Xiaoyuan  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 3, 2013-04 ,pp. : 257-269

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized medicine

By Chen James J   Lin Wei-Jiun   Chen Hung-Chia  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 969-980

Future Medicine

Access to resources Recommend Favorite